The analyses of C, H, N and S are convenient with the stoichiometry of Mg
+2: CFX is in molar ratio (1:1) (Mg:CFX). Molar conductivity value (19 Ω
-1cm
2 mol
-1) that convenient within the range of the non-electrolytic characters (
Geary, 1971) proposing that chloride ion is inside the chelation sphere.
Infrared spectra
IR for CF and CF/Mg are shown in (Fig 1) are similar in the range of 3400-2600 cm
-1 due to vibrational stretching of (O-H), (N-H) and (C-H) aromatic (
Al-Thubaiti et al., 2022). The IR spectrum of cefotaxime has a band appears at 1775 cm
-1 characterized to lactam (carbonyl group C=O), while the amide and ester (C=O) bands are appeared and then interfered at “1642 cm
-1”; while magnesium complexity the range of bands at of 1700-1652 cm
-1 appeared so CF coordinated via the “O” atom of (C=O) lactam group other than (C=O) , amide and then ester groups due to the bands of (C=O) lactam group, which were then shifted towards less frequencies (15-40 cm
-1). The bands ranged between 664-553 cm
-1 for CF complexity are assigned to ν (M-O), that are not monitored in the spectra of CF alone.
New bands that appeared for Mg/CF complexity at 490-521 cm
-1 might assigned to υ (M-N) (from NH
2 group) that are not present in CF suggesting that CF chelated as a chelating agent with tridentate with characters as monoanionic (
Nakamoto, 1986). Based on the obtained data, CF chelates with metal ions as a tridentate
via the β-lactam carbonyl group, carboxylate and amino groups.
The UV-Vis spectra
The “uv-vis” spectra for both CF and CF/Mg complex is presented in Table (1). Cefotaxime has three absorption maxima at 274 nm which is assigned to π → π*, 325 nm due to intraligand of π → π* transitions with heterocyclic moiety (
Franchini et al., 1985;
Hadjikostas et al., 1987). Band at 355 nm is due to intraligand transition of sulphur atoms of n → π* . The band due to S atoms is not shifted suggesting that S atom is not chelated with CF. The magnesium (II) show weak bands at 280,320 and 385 nm may be assigned to π → π* and n → π* transitions.
XRD, SEM and TEM analysis
X-ray diffraction analysis confirm the structure of CF/Mg complex Fig 2. Diffractograms XRD confirmed that CF/Mg has formulating (Amorphous) structure.
The CF/Mg complex was characterized by the X-ray diffraction at 25 C using the Cu Kα radiation. The diffraction characterization of the prepared CF/Mg complex was in between 10
° to 80
°. The semi crystalline nature of CF/Mg determined by using “Scherrer formula” (
Cullity, 1972). The complex semi crystalline size was calculated and has the value of 24 nm.
The image of SEM gives an explanation for the morphological surface of Mg (II) CF that is shown in Fig 3. The image was scanned for Mg (II) using SEM, which made a full check for the morphological phase. (A) CF: The image of SEM shows homogeneity in size with one-piece plate. Meanwhile, (B) CF/MG: showing aggregation shape and size with many grooves and protruded circular formations due to chelation between CF and Mg metal ions.
TEM images for CF and CF/Mg compound Fig 4. (C): CF, which clarifies that CF complexity has a homogeneity in phase material. (D) CF/Mg: Spherical black spots like shapes are shown in magnesium cefotaxime chelates with a particle size range of 16-24 nm.
Antioxidant capacities of CF and it’s Mg metal complex
The estimated percentages obtained of the chelating activity
via using 3 different assays are shown in Table 2. Metal chelation, the assay of ABTS and the assay of DPPH were used. The capacity of the CF and CF/Mg complex to scavenge the free radicals of ABTS was 300.51-fold, which is more than CF itself. Meanwhile, the metal chelating activity of CF/Mg was higher than CF itself by 13.06% (µM EDTA eq/mg), respectively.
On the other hand, the scavenging ability of CF/Mg was also the highest by measuring the stability of the DPPH radical at 30.12% (µM trolox eq/mg). Thus, this metal complex has a greater chelating capacity than CF itself (Table 2).
Anticancer activity against PANC-1
The applications of treatment using the metal drug complex in the biomedical fields have been approved for the treatment of a lot of cancer types. The CF/Mg metal ion complex has been assessed against pancreatic cancer (PANC-1). In the current study, the cytotoxicity of CF/Mg was tested on PANC-1 (pancreatic ductal adenocarcinoma cells, which are a type of pancreatic cancer). It is an epithelioid, highly characterized cell line derived from a human pancreatic carcinoma that showed that the biosynthesized CF/Mg reported the measuring of the cytotoxicity against the PANC-1 cancer cells. This was also greatly reinforced by the increment of the concentration of the “CF/Mg” metal complex. The inhibition of pancreatic cancer cell growth and decrease in the cellular viability that appeared in PANC-1 cells treated with the metal complex “CF/Mg” was recorded at the following concentrations: 10 and 100 ug/ml as follows: 90.87 and 77.58 µg/ml, respectively, causing this loss in PANC-1 cellular growth and viability, as shown in Table 3.
CF is an antibiotic drug used to treat several of the bacterial infections in humans, animals and plant tissue culture. It is used in the humans to treat the joint infections, pelvic inflammation, urinary tract infections, meningitis, pneumonia and sepsis via I.V or I.P injection (
The American Society of Health-System Pharmacists, 2016).
CF was firstly discovered in 1976 and it was in the commercial use in 1980 (
Hamilton.,2015; Newbould.,2012). It is a broad-spectrum antibiotic with activity against numerous gram (+ve and -ve) bacteria with resistance to β-lactams such as penicillin (
Al-Thubaiti et al., 2022).
Metals have an essential and vital key role in the actions of different metallo-antibiotics, as they are essentially involved in their interactions with specific proteins, cellular membranes and other biological molecules (
Fischer and Ganellin, 2006).
CF interacts with metal ion (Mg) to give CF/Mg metal complex which was characterized by spectroscopic methods is suggested for its structure. CF behaves as monoanionic tridentate ligand. The complex has been screened for anticancer and antioxidant capacities against pancreatic cancer cell lines (PANC-1) and via testing the antioxidant activities by ABTS, metal chelation and DPPH tests.
The essential coordination of CF via the NH
2-thiazole, β-lactam (C=O) group and carboxylate; thus it may behave as tridentate ligands
(Masoud et al., 2015). CF was coordinated via not only “O” atoms of β-lactam group “C=O” and group of amide but also via the N-atom of thiazole ring, thus it may act as tridentate ligand as proved in the current study
(Alekseev et al., 2013).
Regarding the multi bacterial resistance, the recent discovery of the novel antibiotics is of a great effect. Many bacterial types, release β-lactamase enzyme in huge amounts, thus they have the ability to breakdown the β-lactam ring
(Hamza et al., 2022; Anacona and Estacio, 2006).
The oxidative injury to the biomolecules is of an essential importance in highly risk diseases such as cancer and serious diseases and pandemic. Thus, it is an essential need to investigate the key and vital role of the metal drug complexes to diminish the severe oxidative damage.
The current results confirmed that the novel antioxidant activity of CF/Mg complex by investigating it’s antioxidant capacities; this increased the efficacy of CF, as it acquire two capacities as antioxidant and anticancer agent also. Thus, synthesizing a novel CF/Mg is helping to alleviate the oxidative damage in a lot of infectious and cancer diseases.
DPPH and metal chelation assays are used to predict with the antioxidants that may act to scavenge the DPPH free radicals and capture the metals, therefore, evaluate the free-radical scavenging capacities (
El-Megharbel and Hamza, 2022). The current results afforded that CF complex with Mg, scavenged significantly DPPH free radicals, thus CF/Mg complex had higher antioxidant activity.
A previous report confirmed that ABTS is vital for the antioxidant capacities, that evaluates the capacities of the synthetic antioxidant to eliminate the free radicals produced by ABTS which are generated in the liquid phase, compared with a Trolox (water-soluble vitamin E analogue) (
El-Megharbel and Hamza, 2022); the current results proved that the CF/Mg complex exhibited strong antioxidant capacity.
Mg is essential to have several antioxidant mechanisms of preventing incidence of the pancreatic cancer. The recent evidences indicate that “Mg” deficiency is one of the risk factors for causing the case of insulin resistance and consequently incidence of the type-II diabetes mellitus (
Wang et al., 2013). Previous trials proved that “Mg” supplementation enhances greatly the cellular sensitivity to insulin hormone (
Guerrero-Romero and Rodriguez-Moran, 2011).
Some of the pancreatic cancer cells such as: PANC-1 and MIA- PaCa-2 tumors have a lot of IGF-1 receptors (
Fisher et al., 1996). Previous study indicated that mice with deficient “IGF-1”, with burden of pancreatic tumor cells “JC101” was markedly declined (
Lashinger et al., 2011). In experimental models of “Mg” deficient, a high level of insulin secretion may have a deleterious effect on the pancreatic exocrine part in patients with type-II diabetes mellitus, leading to the mutation of tumors (
Jansen et al., 2012).
Previous studies have shown that the PANC-1 cells with their main insulin receptors which have a high affinity for the hormone of insulin (
Fisher et al., 1996). Previous studies also indicated that insulin hormone promotes the pancreatic cancer’s growth in hamster “ H2T” (
Fisher et al., 1998) and several other pancreatic cancer types including MIA-PaCa-2, PANC-1 and BxPC-3 (
Ding et al., 2000). It was confirmed that there is great association of “Mg” ion deficiency and also PANC-1 might be via the type-II diabetes mellitus and also the insulin resistance.
Mg deficiency is essentially associated with the free radicals levels’ that has the ability to induc DNA damage and incidence of various types of carcinogenesis. Previously, it was found that “Mg” acts as an antagonist against the carcinogenic chemicals as: Pb, Cd and Ni
(Anastassopoulou et al., 2019).
The current study proved that the novel CF/Mg complex inhibited PANC-1 cells, this promising results are in a great accordance with the previous study of
Al-Thubaiti et al. (2022) who synthesized 5 metal complexes of CF and chemically characterized the following complexes: Ca
2+, Cr
+3, Cu
2+, Zn
2+ and Se
4+ and their results proved that the CF metal ion complexes with either Zn or Se inhibited greatly the hepatic cancer cells viability in HepG-2 cells, meanwhile other complexes with chromium , copper and calcium which greatly elevated the antioxidant capacities with different antioxidant assays such as: DPPH, ORAC, ABTS, FARAB and metal chelation tests. As previously proved in the studies of
El-Megharbel et al. (2022);
AlZahrani et al., (2025) and
Al-Thubaiti et al. (2025), which proved this new scientific concept of the potency of metal complexes as potent antioxidant, antibacterial and anticancer activities. The present study results are very promising, since the current study demonstrated the provision of strong protection of CF/Mg against the pancreatic cancer (PANC-1) and a decline in the severe oxidative injury that could generated by excessive use of the antibiotics.